News
published at: 25.04.2025
Research success at Dresden University Hospital: New cell therapy shows promising results in advanced tumor diseases
An international research group led by scientists from the National Center for Tumor Diseases (NCT/UCC) in Dresden has now succeeded for the first time in a phase 1 clinical trial in testing a novel cell therapy approach that also shows promise for solid tumors. The results were now published in the renowned journal Nature Medicine.
published at: 15.04.2025
More options for patients: Advantages of whole genome/RNA sequencing over broad panel analyses
The further development of molecular cancer therapies is a focus at the National Center for Tumor Diseases (NCT/UCC) Dresden. Among other things, genome sequencing is of great interest here, which involves analyzing the genetic material of a cell as comprehensively as possible.
published at: 12.03.2025
Personalized therapies for leukemia: Clinical trial from Dresden and Kiel investigates innovative medication after stem cell transplantation
Acute myeloid leukemia (AML) is an aggressive form of blood cancer that carries a high risk of relapse even after stem cell transplantation. The PIVOT clinical trial, which has now been launched by scientists from Dresden and Kiel, is investigating whether the drug Ivosidenib can help to reduce the risk of relapse and improve patients' chances of survival.
published at: 14.02.2025
Genome sequencing for rare diseases and cancer
The University Hospital Carl Gustav Carus Dresden has been awarded the contract to participate in the model project Genome Sequencing for Tumor Patients and Patients with Rare Diseases.
published at: 03.02.2025
World Cancer Day on February 4: From shadow to light
With the exhibition "From Shadow to Light", six master students from the Dresden University of Fine Arts (HfBK Dresden) approached these questions in 2023/24. After the works by Eric Beier, Noemi Durighello, Hanne Lange, Michael Merkel, Julia Schmelzer and Tillmann Ziola have been on display at the NCT/UCC Dresden for a year, the exhibition will go on tour from February 4. It will initially be on display for almost four weeks at Dresden's Altmarkt-Galerie.
published at: 18.12.2024
RATIONALE focuses on rare cancers: First multi-site study by the National Center for Tumor Diseases (NCT)
Recruitment for RATIONALE will begin at the NCT in 2025. The study is investigating the benefits of molecularly controlled treatment for patients with rare cancers. The researchers want to prove that the progression-free survival of patients with advanced rare cancers can be doubled compared to standard therapy. For the first time, all six NCT sites are pooling their joint expertise in a study involving patients throughout Germany.
published at: 16.12.2024
EU millions for Dresden to develop portable quantum sensors: State of the art from quantum computing is set to open up new possibilities in neurosurgery
Researchers from Dresden want to bring sensors that have so far only been used in quantum computing and communication to the operating room. An EU grant totaling EUR 5 million over four years is supporting the consortium in developing and implementing this technology.
published at: 11.12.2024
Forbes “30 under 30”: UKD physician Fiona Kolbinger is one of the most promising young scientists
In December, Forbes magazine named Dr. Fiona Kolbinger one of the most influential young scientists on its famous “30 under 30 North America 2025” list. With her research at the interface between surgery, data science and computer science, Kolbinger is developing pioneering AI methods for improved treatment in difficult operations.
published at: 05.11.2024
ERC Synergy Grant for ClonEScape: Tracking the development of tumors
A research alliance from Cambridge (Great Britain), Daejeon (South Korea) and Dresden is working to shed some light on the origin of clonal pathogenesis with the joint project "ClonEScape". For this project, the scientists Prof. Benjamin Simons (University of Cambridge), Dr. Maria Alcolea (University of Cambridge), Dr. Bon-Kyoung Koo (Institute for Basic Science) and Prof. Daniel Stange (TU Dresden) have been awarded the prestigious Synergy Grant of the European Research Council (ERC) alongside funding amounting to almost EUR 10M.
published at: 02.10.2024
Dresden researchers receive funding award for developing AI models for leukemia detection in bone marrow
Digitalization is playing an increasingly important role in laboratories as well. The use of artificial intelligence in data analysis significantly expands possibilities in the areas of diagnostics and individualized therapies. Therefore, the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) awards the Digital Laboratory Funding Prize for outstanding scientific achievements.
published at: 18.09.2024
New imaging procedures in cancer surgery: Helmholtz High Impact Award for Oliver Bruns and Ellen Sletten
18.09.2024: Biochemist Oliver Bruns (NCT/UCC Dresden) and chemist Ellen Sletten (UCLA) have been presented with the Helmholtz High Impact Award 2024 by the Helmholtz Association and the “Stifterverband für die Deutsche Wissenschaft” for their research into an innovative medical imaging technology in the short-wave infrared range. The procedure they have developed has the potential to significantly improve surgical removal of tumors. At yesterday’s award ceremony in Berlin, the two scientists were presented with the award – endowed with € 50,000 – in recognition of their interdisciplinary research.
published at: 30.08.2024
NCT/UCC Dresden: Millions in funding from the Chan Zuckerberg Initiative for state-of-the-art imaging to accurately detect minute tumors
30.08.2024: An international group of scientists led by Prof. Oliver Bruns (NCT/UCC Dresden), Dr. Andriy Chmyrov (NCT/UCC Dresden), Prof. Ellen Sletten (UCLA) and Prof. Christopher Rowlands (Imperial College London) has once again received renowned funding from the Chan Zuckerberg Initiative. With their research, the team strives to improve imaging in deeper tissue layers.
published at: 11.07.2024
Acute Myeloid Leukemia: Germany-wide clinical trial challenges international standard of care
published at: 11.07.2024
Acute myeloid leukemia: Longer time frame for decision-making when starting therapy
published at: 11.07.2024